Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review

G Giuffrida, U Markovic, A Condorelli… - Orphanet journal of rare …, 2023 - Springer
Background Gaucher disease (GD) is a rare, inherited, autosomal recessive disorder
caused by a deficiency of the lysosomal enzyme, acid β-glucosidase. Its diagnosis is …

Phagocytosis of erythrocytes from gaucher patients induces phenotypic modifications in macrophages, driving them toward gaucher cells

L Dupuis, M Chauvet, E Bourdelier, M Dussiot… - International Journal of …, 2022 - mdpi.com
Gaucher disease (GD) is caused by glucocerebrosidase deficiency leading to the
accumulation of sphingolipids in macrophages named “Gaucher's Cells”. These cells are …

An update on sphingolipidomics: Is something still missing? Some considerations on the analysis of complex sphingolipids and free-sphingoid bases in plasma and …

C Morano, A Zulueta, A Caretti, G Roda, R Paroni… - Metabolites, 2022 - mdpi.com
The main concerns in targeted “sphingolipidomics” are the extraction and proper handling of
biological samples to avoid interferences and achieve a quantitative yield well representing …

Red Blood Cells: A Newly Described Partner in Central Retinal Vein Occlusion Pathophysiology?

S Laurance, M Marin, Y Colin - International Journal of Molecular …, 2023 - mdpi.com
Central retinal vein occlusion (CRVO) is a frequent retinal disorder inducing blindness due
to the occlusion of the central vein of the retina. The primary cause of the occlusion remains …

Hydrogen peroxide diffusion across the red blood cell membrane occurs mainly by simple diffusion through the lipid fraction

F Orrico, AC Lopez, N Silva, M Franco… - Free Radical Biology …, 2025 - Elsevier
Abstract Hydrogen peroxide (H 2 O 2) is an oxidant produced endogenously by several
enzymatic pathways. While it can cause molecular damage, H 2 O 2 also plays a role in …

a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy

M Moraitou, G Sotiroudis, N Papagiannakis… - Plos one, 2023 - journals.plos.org
It is well established that patients with Gaucher disease, as well as carriers of the disease
have an increased risk for developing Parkinson's disease. A plethora of evidence suggests …

Development of a new online SPE-HPLC-MS/MS method for the profiling and quantification of sphingolipids and phospholipids in red blood cells–Application to the …

T Bettioui, C Chipeaux, KB Arfa, S Héron… - Analytica Chimica …, 2023 - Elsevier
Red blood cells (RBCs) are the subject of clinical attention due to their biological
importance. Recently, it has been shown that certain erythrocyte pathologies could be linked …

RBC-GEM: a Knowledge Base for Systems Biology of Human Red Blood Cell Metabolism

ZB Haiman, B Palsson, A D'Alessandro - bioRxiv, 2024 - biorxiv.org
Advancements with cost-effective, high-throughput omics technologies have had a
transformative effect on both fundamental and translational research in the medical …

Analytical considerations for reducing the matrix effect for the sphingolipidome quantification in whole blood

D Wang, P Xu, C Mesaros - Bioanalysis, 2021 - Taylor & Francis
Aim: Plasma and serum are widely used blood-derived biofluids for metabolomics and
lipidomics assays, but analytes that are present in high concentrations in blood cells cannot …

In silico biophysics and rheology of blood and red blood cells in Gaucher Disease

Z Chai, G Li, PA Ndour, P Connes, PA Buffet, M Franco… - bioRxiv, 2024 - biorxiv.org
Gaucher Disease (GD) is a rare genetic disorder characterized by a deficiency in the
enzyme glucocerebrosidase, leading to the accumulation of glucosylceramide in various …